DANIEL D BURGESS
CIK 1239650 · COO/CFO · last filed 2026-01-07
DANIEL D BURGESS is a COO/CFO who has filed 51 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider disposed of $33.2K of CDTX on Jan 7, 2026. Across all open-market trades the lifetime net is −$535.6K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
6
51
-$535.6K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Cidara Therapeutics, Inc. (CDTX) Delisted | Director | 0 | $221.38 | $0 | $48.0K | 14 | 2026-01-07 |
| ABUS | Director | — | $4.26 | — | $0 | 9 | 2024-05-24 |
| Nabriva Therapeutics plc (NBRV) Delisted | Director | 10,384 | $1.42 | $14.7K | $95.5K | 8 | 2022-08-04 |
| SANTARUS INC (SNTS) Delisted | Director | 0 | — | — | -$666.7K | 14 | 2013-06-12 |
| MBRX | Director | — | $2.64 | — | $0 | 3 | 2009-06-24 |
| Harbor BioSciences, Inc. (HEPH) Delisted | COO/CFO | 12,209 | — | — | -$12.4K | 1 | 2007-02-15 |
Recent Filings
51 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-07 | Cidara Therapeutics, Inc. (CDTX) Delisted | Disp (D) | −150 | -$33.2K | EDGAR |
| 2025-06-18 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-12-19 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-07-19 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-05-24 | ABUS | Grant (A) | — | $0 | EDGAR |
| 2023-06-23 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-26 | ABUS | Grant (A) | — | $0 | EDGAR |
| 2022-08-04 | Nabriva Therapeutics plc (NBRV) Delisted | Sell (S) | −11,341 | -$2.2K | EDGAR |
| 2022-06-24 | Cidara Therapeutics, Inc. (CDTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-26 | ABUS | Grant (A) | — | $0 | EDGAR |